IMPACT BIOMEDICAL INC (IBO) Stock Price & Overview
NYSEARCA:IBO • US45259L2051
The current stock price of IBO is 0.5401 USD. Today IBO is down by -1.8%. In the past month the price increased by 20.46%.
IBO Key Statistics
- Market Cap
- 56.505M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -3.58
- Dividend Yield
- N/A
IBO Stock Performance
IBO Stock Chart
IBO Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to IBO.
IBO Earnings
IBO Forecast & Estimates
IBO Groups
Sector & Classification
IBO Financial Highlights
Over the last trailing twelve months IBO reported a non-GAAP Earnings per Share(EPS) of -3.58. The EPS decreased by -509.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -201.86% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
IBO Ownership
IBO Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 28.04 | 943.209B | ||
| JNJ | JOHNSON & JOHNSON | 20.8 | 585.582B | ||
| MRK | MERCK & CO. INC. | 22.22 | 287.316B | ||
| PFE | PFIZER INC | 8.99 | 155.235B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.33 | 122.147B | ||
| ZTS | ZOETIS INC | 16.93 | 50.567B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.87 | 26.934B | ||
| VTRS | VIATRIS INC | 5.5 | 16.085B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.82 | 11.659B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.158B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.518B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.968B | ||
| LGND | LIGAND PHARMACEUTICALS | 23.33 | 4.412B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About IBO
Company Profile
Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2024-09-16. The company discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. The company has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. The company also evaluates additional technologies.
Company Info
IPO: 2024-09-16
IMPACT BIOMEDICAL INC
1400 Broadfield Blvd., Suite 130
Houston TEXAS US
Employees: 2
Phone: 15852321500
IMPACT BIOMEDICAL INC / IBO FAQ
What does IMPACT BIOMEDICAL INC do?
Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The company is headquartered in Houston, Texas and currently employs 2 full-time employees. The company went IPO on 2024-09-16. The company discovers, confirms, and patents science and technologies, which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships. The company has several technologies that are in continuing development, which include Linebacker, Laetose, Functional Fragrance Formulation (3F), Equivir/Equivir G, and Celios. Linebacker is a platform of small molecule electrophilically enhanced polyphenol compounds with potential application in oncology (solid tumors), inflammatory disorders, and neurology. Laetose technology is derived from a combination of multiple sugars independently with myo-inositol. 3F is a suite of organic functional fragrances. Celios is an air purification technology. The company also evaluates additional technologies.
What is the current price of IBO stock?
The current stock price of IBO is 0.5401 USD. The price decreased by -1.8% in the last trading session.
Does IBO stock pay dividends?
IBO does not pay a dividend.
What is the ChartMill rating of IMPACT BIOMEDICAL INC stock?
IBO has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
What is the market capitalization of IBO stock?
IMPACT BIOMEDICAL INC (IBO) has a market capitalization of 56.51M USD. This makes IBO a Micro Cap stock.